IMIO
PrivateLast Round
Seed
Oct 20, 2026
Total Funding Raised
$18.22M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
IMIO operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Seed round in October 2026.
IMIO is an agricultural technology company that develops and manufactures all-natural microbial inoculants designed to break down crop residue and improve soil health, enabling farmers to increase crop yields.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IMIO Comparables
Compare IMIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DPH Biologicals | 83% | |
| Dakota Bio | 82% | |
| Biodyne USA | 81% |
For institutional investors. Book with your work email.
IMIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 20, 2026 | ||||
| Strategic | Jul 16, 2026 | ||||
| VC Round | Jan 1, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
IMIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Starshot Capital | VC Round, Seed, Strategic |
| Nextwave X Partners | Seed |
| Serra Ventures | VC Round, Seed |
| Earth Foundry | Seed |
| Sofinnova Partners | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 20, 2026
$12M round led by Sofinnova Partners.
- Jul 24, 2026
Monthly visitors increased 74% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- invests_into_assetsOct 20, 2026
IMIO raises $12M, with Sofinnova as lead, to build a laboratory and biomanufacturing facility in Illinois in Oct '26.
- receives_financingOct 20, 2026
IMIO raises a $12M Seed round led by Sofinnova Partners and supported by Chipotle’s Cultivate Next venture fund, Starshot Capital, Grow Together Salinas, Earth Foundry, and Serra Ventures to expand its team, increase production capacity, and build a biomanufacturing and R&D facility in Chicago.
For institutional investors. Book with your work email.
IMIO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IMIO's valuation, stock price, and market status.
Is IMIO a public or private company?
IMIO is a private company.
What is the current stock price of IMIO?
IMIO is a private company, so its shares have no public market price. Caplight tracks IMIO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IMIO worth (valuation)?
Valuation information for IMIO is not publicly available.
Can I buy IMIO stock?
IMIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IMIO's last funding round?
IMIO's most recent funding round was Seed on October 20, 2026.
Who are the main investors in IMIO?
Key investors in IMIO include Starshot Capital, Sofinnova Partners.
Will IMIO IPO soon?
No public IPO plans have been announced for IMIO.
How can I track IMIO secondary market activity?
Caplight tracks bids, offers, and trades in IMIO's shares on secondary markets.